Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily White

Showing results (381-390 of 466) with videos related to

Pageof 47
Sort By:
Annals of Epidemiology|November 21, 2022
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ProgramHilary A Robbins, Karine Alcala, Elham Khodayari Moez, et al.
International Journal of Cancer|December 19, 2018
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort ConsortiumRenée T Fortner, Elizabeth M Poole, Nicolas A Wentzensen, et al.
British Journal of Cancer|January 15, 2016
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer riskXabier Garcia-Albeniz, Anja Rudolph, Carolyn Hutter, et al.
International Journal of Epidemiology|November 27, 2018
Mendelian randomization analysis of C-reactive protein on colorectal cancer riskXiaoliang Wang, James Y Dai, Demetrius Albanes, et al.
Carcinogenesis|June 14, 2015
Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancerHamed Khalili, Jian Gong, Hermann Brenner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2020
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer RiskNikhil K Khankari, Barbara L Banbury, Maria C Borges, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2020
A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal CancerAayah Nounu, Alexander Greenhough, Kate J Heesom, et al.
HGG Advances|January 20, 2022
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosisGail P Jarvik, Xiaoliang Wang, Pierre Fontanillas, et al.
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Journal of the National Cancer Institute|May 26, 2019
Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective StudiesEmma E McGee, Sarah S Jackson, Jessica L Petrick, et al.
Pageof 47

Showing results (381-390 of 466) with videos related to

Sort By:
Pageof 47
Annals of Epidemiology|November 21, 2022
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ProgramHilary A Robbins, Karine Alcala, Elham Khodayari Moez, et al.
International Journal of Cancer|December 19, 2018
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort ConsortiumRenée T Fortner, Elizabeth M Poole, Nicolas A Wentzensen, et al.
British Journal of Cancer|January 15, 2016
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer riskXabier Garcia-Albeniz, Anja Rudolph, Carolyn Hutter, et al.
International Journal of Epidemiology|November 27, 2018
Mendelian randomization analysis of C-reactive protein on colorectal cancer riskXiaoliang Wang, James Y Dai, Demetrius Albanes, et al.
Carcinogenesis|June 14, 2015
Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancerHamed Khalili, Jian Gong, Hermann Brenner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2020
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer RiskNikhil K Khankari, Barbara L Banbury, Maria C Borges, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2020
A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal CancerAayah Nounu, Alexander Greenhough, Kate J Heesom, et al.
HGG Advances|January 20, 2022
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosisGail P Jarvik, Xiaoliang Wang, Pierre Fontanillas, et al.
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Journal of the National Cancer Institute|May 26, 2019
Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective StudiesEmma E McGee, Sarah S Jackson, Jessica L Petrick, et al.
Pageof 47